MATRIX-RARE
– Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment; matrixrare.no
- EudraCT number: 2024-513779-42-02
- Clinicaltrials.gov: NCT06119789
| Background/study objectives |
| Study design |
| Collaborative partners |
| Update/publications |